11:02 AM EST, 11/17/2025 (MT Newswires) -- GoodRx ( GDRX ) introduced a weight loss telemedicine subscription that connects consumers to licensed health-care providers, offering an introductory cash price of $199 per month for Ozempic and Wegovy through a partnership with Novo Nordisk ( NVO ) .

The telemedicine service is priced at $39 a month through January, increasing to $119 starting Feb. 1, GoodRx ( GDRX ) said Monday in a statement.

The promotional pricing for Ozempic and Wegovy applies to the first two fills of the two lowest doses, after which the cost rises to $349 per month for subsequent prescriptions.

"By uniting nationwide pharmacy integration, home delivery capabilities, and transparent pricing in one seamless experience, GoodRx ( GDRX ) is creating a higher standard for affordability and trust in weight loss care," Chief Executive Officer Wendy Barnes said in the statement.

GoodRX ( GDRX ) shares fell 0.7% in recent Monday trading, and Novo rose 0.8%.

Price: 2.95, Change: -0.02, Percent Change: -0.67